Vext Science, Inc.
VEXTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.5% | 16% | 13.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 31.3% | 36.3% | 19.7% | 20.9% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 14.8% | 39.6% | 8.7% | -19.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.7% | -11% | -28.8% | -90.4% |
| EPS Diluted | -0.011 | -0.006 | -0.014 | -0.05 |
| % Growth | -72.1% | 54.8% | 72.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |